COYA
Price
$6.02
Change
-$0.52 (-7.95%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
109.38M
35 days until earnings call
KNSA
Price
$21.75
Change
-$0.10 (-0.46%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.59B
33 days until earnings call
Ad is loading...

COYA vs KNSA

Header iconCOYA vs KNSA Comparison
Open Charts COYA vs KNSABanner chart's image
Coya Therapeutics
Price$6.02
Change-$0.52 (-7.95%)
Volume$379
Capitalization109.38M
Kiniksa Pharmaceuticals International
Price$21.75
Change-$0.10 (-0.46%)
Volume$10.84K
Capitalization1.59B
COYA vs KNSA Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. KNSA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and KNSA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (COYA: $6.54 vs. KNSA: $21.85)
Brand notoriety: COYA and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 25% vs. KNSA: 56%
Market capitalization -- COYA: $100.68M vs. KNSA: $1.59B
COYA [@Biotechnology] is valued at $100.68M. KNSA’s [@Biotechnology] market capitalization is $1.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 5 TA indicator(s) are bullish while KNSA’s TA Score has 6 bullish TA indicator(s).

  • COYA’s TA Score: 5 bullish, 3 bearish.
  • KNSA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both COYA and KNSA are a good buy in the short-term.

Price Growth

COYA (@Biotechnology) experienced а +0.46% price change this week, while KNSA (@Biotechnology) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

COYA is expected to report earnings on May 08, 2025.

KNSA is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.59B) has a higher market cap than COYA($109M). COYA YTD gains are higher at: 14.136 vs. KNSA (10.465). COYA has higher annual earnings (EBITDA): -11.33M vs. KNSA (-43.92M). KNSA has more cash in the bank: 244M vs. COYA (31.1M). KNSA has higher revenues than COYA: KNSA (423M) vs COYA (9.55M).
COYAKNSACOYA / KNSA
Capitalization109M1.59B7%
EBITDA-11.33M-43.92M26%
Gain YTD14.13610.465135%
P/E RatioN/A164.54-
Revenue9.55M423M2%
Total Cash31.1M244M13%
Total DebtN/A9.86M-
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAKNSA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 15 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZMX155.141.26
+0.82%
Oakmark R6
PAGYX19.53N/A
N/A
Putnam Dynamic Asset Allocation Gr Y
SEGIX38.68N/A
N/A
NAA Large Cap Value C
JTUAX15.47N/A
N/A
JPMorgan US Small Company A
PFPFX51.10N/A
N/A
Poplar Forest Partners A

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with TENX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+3.65%
TENX - COYA
33%
Loosely correlated
-0.94%
KNSA - COYA
33%
Loosely correlated
+0.37%
GANX - COYA
30%
Poorly correlated
+4.42%
INDP - COYA
28%
Poorly correlated
-3.65%
NTLA - COYA
27%
Poorly correlated
+9.69%
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with FATE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.37%
FATE - KNSA
42%
Loosely correlated
+1.70%
ABVC - KNSA
40%
Loosely correlated
-16.29%
BEAM - KNSA
37%
Loosely correlated
+4.79%
NTLA - KNSA
37%
Loosely correlated
+9.69%
AMRN - KNSA
36%
Loosely correlated
-2.26%
More